62Cu ETS - Proportional Technologies

Drug Profile

62Cu ETS - Proportional Technologies

Alternative Names: (62)Cu-ethylglyoxal bis(thiosemicarbazonato)copper(II) - Proportional Technologies

Latest Information Update: 24 Apr 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Proportional Technologies
  • Class Imaging agents; Radiopharmaceutical diagnostics
  • Mechanism of Action Positron-emission tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Cancer; Renal failure

Most Recent Events

  • 28 Feb 2017 Discontinued - Phase-II for Renal failure (Diagnosis) in USA (IV) (NCT00714142)
  • 30 Aug 2016 Discontinued - Clinical-Phase-Unknown for Cancer (Diagnosis) in USA (IV)
  • 30 Aug 2016 Discontinued - Clinical-Phase-Unknown for Cancer (Diagnosis, In volunteers) in USA (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top